Match sleeve size to each session to cut waste and costs, without compromising control
In this article, you’ll learn:
How the in-use period after opening a sleeve drives avoidable plate waste
Why the real cost of a sleeve is the cost per plate actually used
Why a smaller sleeve is only greener when it means fewer discarded plates
What EU Good Manufacturing Practice (GMP) Annex 1 expects when materials such as plates are transferred into higher-grade cleanrooms
How residual hydrogen peroxide can affect media in isolators, and why protective packaging matters
The questions to ask before changing sleeve size, and which Redipor® formats are available in smaller sleeves
The right plate sleeve size is the one that matches the number of plates a session or monitoring round uses, because plates left in an opened sleeve must be used within a short in-use period or discarded. A smaller sleeve containing fewer plates should reduce that waste without weakening the transfer route, protection, or traceability that a site’s contamination control strategy (CCS) relies on. In response to customer requests, we’ve launched smaller sleeve sizes that can reduce waste, coupled with environmental and cost benefits.
A sleeve size chosen without reference to the workflow either sends usable plates, and the money spent on them, to disposal, or weakens the evidence that shows an aseptic process is under control.
Ready-to-use culture media plates provide the microbiological evidence that contamination control is working, which makes them essential to aseptic processing and patient protection. Yet once a sleeve is opened, any plates that aren’t needed during a session are often discarded. The practical issue isn’t how much packaging can be reduced, but how to receive the number of plates a session needs, in the appropriate condition, without opening a larger sleeve than necessary. Matching sleeve size to use means supplying prepared plates in sleeves sized to a typical session or monitoring round, so that the number of plates in an opened sleeve equals the number used.
Every plate also carries an environmental cost: materials, manufacture, packaging, irradiation where applicable, transport, controlled storage, and disposal. Supply chains are a major part of healthcare’s environmental footprint, and the World Health Organization’s guidance on decarbonizing them focuses on supplier decarbonization through procurement, and on optimizing the demand for and use of products [1].
Many customers have asked us for smaller sleeves because they were using only two or three plates from a ten-plate sleeve and discarding the rest. Every one of those plates had already been made, quality tested, packed, and shipped, so the waste starts long before disposal. The appropriate sleeve size is the one where every plate a lab opens produces a result. That’s where efficiency, cost, and sustainability meet.
— Yoggya De Silva, Product Manager, Culture Media, Life Sciences Portfolio, AnalytiChem Group
It’s important to note that sleeve size choice isn’t simply a matter of plate count, because sustainability and cost savings can’t come at the expense of product quality, patient safety, or reliable microbial recovery.
Current Redipor storage guidance states that once a sleeve of ten irradiated plates is opened, the plates should be used within one day, while non-irradiated plates should be used within one to three days of opening. This is because exposed agar can dehydrate or become contaminated [2]. Unopened, most irradiated media has a six-month shelf life, and non-irradiated plates typically have a shelf life of eight weeks to three months [2], so the in-use period is usually the tighter constraint, and the point where the largest avoidable loss happens.
Opening a ten-plate sleeve for a session that needs three plates can therefore mean discarding the other seven plates if they can’t be used in another session on the same day. Sleeves containing two, three, four, or five plates let the quantity in the opened sleeve match the session requirements, from two plates for a pair of finger dabs to five for a short monitoring round. Ten-plate sleeves remain efficient where a full sleeve is reliably used within the in-use period, for example, when several rooms are sampled in sequence.
While smaller sleeves carry a higher price per plate than ten-plate sleeves, they can cost less per plate actually used, because plates discarded from an opened sleeve have been paid for without producing a result. A lab that uses three plates from a ten-plate sleeve pays for ten plates to get three results, more than tripling the effective cost of each plate used. Similarly, using five plates from a ten-plate sleeve doubles the effective cost.
The more plates a lab discards from each sleeve, the stronger the case for switching to a smaller sleeve size. For procurement and finance teams, the comparison shifts from price per plate to cost per usable result.
A smaller plate sleeve isn’t automatically more sustainable, because visible waste isn’t always the most significant environmental hotspot. A state-of-the-science review of hospital services and care pathways found that travel, facilities, and consumables were key contributors to carbon footprints, whereas waste disposal made a smaller contribution, and that the balance differed between services and settings [3].
The same applies to prepared media: a smaller sleeve can reduce unused plates in one workflow, yet add packaging per plate, transfers, or deliveries in another. In life cycle assessment terms, the appropriate functional unit is the plate actually used, not the sleeve delivered, so plates discarded after opening, stock that expires unused, and extra emergency deliveries all count. This shifts the question from how much packaging arrives on site to how many plates leave the cleanroom without having produced a result.
In biopharmaceutical manufacturing, the sustainability debate often centers on single-use plastics, which bring operational and contamination control benefits. A recent scoping review found that the available life cycle assessments, although limited to single processes or companies, reported lower overall impacts for single-use technology than for stainless steel, reflecting the water and energy saved by avoiding clean-in-place and steam-in-place cycles. End-of-life accounted for only a small proportion of the total, and evidence on circularity and end-of-life remains scarce [4]. Prepared media deserves the same whole-life view.
Under Annex 1 of the EU Guidelines for Good Manufacturing Practice, Manufacture of Sterile Medicinal Products, environmental monitoring forms part of a facility-wide CCS, and monitoring or testing alone doesn’t provide assurance of sterility [5]. A CCS is a planned set of controls for microorganisms, endotoxin/pyrogen, and particles, derived from current product and process understanding, that assures process performance and product quality [5]. The reason monitoring alone isn’t sufficient is partly statistical: each method samples only a small fraction of the air or surfaces and recovers only some of the organisms present, which is also why Annex 1 asks for data on the recovery efficiency of the methods chosen [5]. A risk-based program, informed by process knowledge, qualification and routine data, air visualization studies, and the local flora, defines where, how often, and how to sample and incubate [5]. Prepared plates and their packaging touch every stage of that workflow:
Annex 1 describes the transfer of equipment and materials into and out of cleanrooms and critical zones as one of the greatest potential sources of contamination. Where items can’t be sterilized on transfer, it expects a validated procedure that achieves the same objective, such as an effective transfer disinfection process or a rapid transfer system for isolators. It also recognizes, where justified, sterile packs with multiple coverings removed at each transfer from a lower to a higher grade [5]. Removing layers to save material can undermine a validated transfer route, so a change of sleeve size should leave protection around the plates unchanged.
Isolators and restricted access barrier systems (RABS) help minimize contamination from direct human intervention in the critical zone, but their transfer and bio-decontamination processes still have to be validated within the site’s CCS [5]. Vaporized hydrogen peroxide (VHP) adds a further consideration: a study found that residual hydrogen peroxide at levels as low as 1 part per million (ppm) can remain in an isolator after decontamination and inhibit microbial growth on agar used for air monitoring, with a risk of false-negative results [6]. In the same study, catalase was not a sufficiently effective neutralizer, but adding 1% pyruvate, which scavenges hydrogen peroxide, allowed all six test organisms to grow at up to 15 ppm [6]. A false negative is a particular concern, because it reports control that may not exist.
Where VHP is used, protective packaging is therefore functional rather than excessive. Redipor VHP-resistant packaged plates are irradiated and sealed in a VHP-impermeable layer, and every batch undergoes growth promotion testing after irradiation [7]. The packaging has been tested at peak VHP concentrations with no ingress detected [8]. Using detectors sensitive to below 1 ppm, no hydrogen peroxide was found inside the packs, even after repeated exposure cycles peaking at 927 ppm [7].
The Redipor BetaBag is a closed transfer system that docks with a 190 mm alpha port on an isolator or RABS [8, 9]. A 60° turn locks the bag’s beta connection to the alpha port and joins their doors into a single, lip-sealed unit that opens without breaking sterility [10]. Gamma-irradiated plates, in standard ten-plate sleeves, or in smaller sleeves as a tailor-made option, can therefore pass aseptically into the Grade A environment. When validated within the site’s CCS, the Redipor BetaBag removes the need for the VHP cycles otherwise associated with introducing prepared media. VHP cycles need validating, and each run takes aeration time and draws on labor, utilities, and cleanroom capacity, so removing them saves both time and energy [9]. The Redipor BetaBag enables sleeves to be introduced in stages as needed, and can be attached up to four times without compromising its seal [9]. To learn more, read our blog about the Redipor BetaBag, which includes an animated explainer.
Yes, smaller sleeves suit hospital pharmacy aseptic services because these units often run short sessions with workloads that change with patient demand, so plate requirements vary from day to day. Smaller sleeves fit short compounding sessions, lower-frequency cleanroom or isolator monitoring, operator qualification and requalification, small-scale aseptic process simulations, and investigations requiring only a few plates.
Routine monitoring in these settings can involve very few plates. In Dutch hospital pharmacies, microbiological monitoring during aseptic handling, in relation to manufacturing of sterile products within a closed system that are ready to be administered, typically uses one settle plate, one glove print, and one worktop contact plate per working day [11]. In the US, United States Pharmacopeia (USP) General Chapter <797> requires gloved fingertip and thumb sampling at least every six months, and surface sampling at least monthly, for Category 1 and 2 sterile compounding [12]. Because an opened sleeve of irradiated plates should be used within one day [2], a unit that needs only a handful of plates, or runs a single short session and then pauses, is where a ten-plate sleeve is most likely to be only part-used.
Many hospital units work to GMP or GMP-based standards, so the considerations of transfer route and packaging function apply to them too. Any reduction in waste still needs to be weighed against more frequent deliveries and the need to manage a wider range of stock lines.
Choosing the appropriate sleeve size depends on measured use, cost per plate used, the transfer route, and conditions of use, so the decision should be tested against a short set of questions for each setting.
Where the answers indicate a formulation, plate format, or pack configuration outside the standard range, a tailor-made product from AnalytiChem may be a better fit. And if a change of packaging also means a change of supplier, our guide to Evaluating and Validating Potential New Suppliers of Prepared Microbiology Media sets out what to consider.
Redipor 90 mm Petri dishes and 55 mm contact plates are available in sleeves of two, three, four, or five plates, as well as ten-plate sleeves, so the sleeve can be matched to the typical session or monitoring round. The 90 mm Petri dishes and contact plates come in both standard and TwistLock formats, the latter offering greater sample security, data integrity, and an optimized workflow. The smaller sleeves are made to order rather than held in stock, and where a formulation isn’t in the active portfolio, it can be supplied through AnalytiChem’s tailor-made service, so smaller sleeves aren’t limited to the formulations in the standard range.
Plate format can also prevent error-driven waste. Where Tryptone Soya Agar (TSA) and Sabouraud Dextrose Agar (SDA) are used side by side, the two media serve different purposes: TSA recovers a broad range of bacteria and fungi, while SDA, with its high glucose content and acidic pH of around 5.6, favors yeasts and molds and suppresses many bacteria. TSA can be supplied in blue-colored, triple-vented 90 mm plates, so operators can tell it apart from SDA in clear plates at a glance, avoiding mix-ups that can lead to repeat sampling.
The most sustainable format is the one that delivers the required microbiological quality with the highest practical utilization and the lowest avoidable burden. For many sites, that points away from packaging volume and toward the plates in an opened sleeve that are left unused. A smaller sleeve earns its place where sessions are short or variable; a ten-plate sleeve remains the efficient choice where every plate is reliably used, because its lower price per plate only counts when every plate produces a result.
Packaging that appears excessive is often doing validated work. Multiple coverings support transfer through increasing cleanroom grades, VHP-impermeable layers protect the agar from peroxide, and a closed transfer system such as the Redipor BetaBag can make redundant the VHP decontamination cycles used to introduce prepared media. Changing packaging without reference to the CCS risks trading a visible saving for a less reliable monitoring result, which is unacceptable for a quality team whose plates provide the evidence that the process is under control.
For a laboratory routinely discarding most of an opened sleeve, a smaller sleeve is the obvious place to start, reducing both waste and the cost of plates that never produce a result. The choice of sleeve size rests on how many plates each room, shift, or session actually uses, how often a sleeve is only partly used, the cost of each plate used, and what the transfer route demands. It’s a decision that should be based on measured workflow data, not the assumption that smaller must mean greener, or that a sleeve containing more plates always means a lower cost per plate used.
Tailor-made products, from packaging and formulation to batch size, are an integral part of AnalytiChem’s Redipor portfolio. If you’re regularly disposing of unused plates, contact our team to discuss Redipor sleeves containing two, three, four, or five plates. If your transfer route, formulation, or workflow calls for something different, fill out this form to request a tailor-made product that meets your lab’s specific requirements.
References
World Health Organization. Decarbonizing the healthcare supply chain: strategic actions for health systems. Geneva: WHO; 2025. Source
AnalytiChem. Redipor® storage conditions: storage temperatures for prepared media. AnalytiChem; 2025. Source
Kouwenberg LHJA, et al. The carbon footprint of hospital services and care pathways: a state-of-the-science review. Environ Health Perspect. 2024;132(12):126002. doi:10.1289/EHP14754. Source
Goggin M, et al. Exploring the sustainability of single use plastics in the biopharmaceuticals sector: a scoping review of challenges, opportunities, and impacts. Front Sustain. 2025;6:1536382. doi:10.3389/frsus.2025.1536382. Source
European Commission. EudraLex Volume 4, Annex 1: Manufacture of Sterile Medicinal Products. Brussels: European Commission; 2022. Source
Ohresser S, Griveau S, Schann C. Validation of microbial recovery from hydrogen peroxide-sterilized air. PDA J Pharm Sci Technol. 2004;58(2):75–80. Source
AnalytiChem. Prepared media in TwistLock plates: sample security, data integrity, optimized workflow. AnalytiChem; 2025. Source
AnalytiChem. Sterility assurance solutions for Annex 1 compliance. AnalytiChem; 2026. Source
AnalytiChem. The Redipor® BetaBag: reducing risk, downtime, and waste in sterile media transfer. AnalytiChem; 2026. Source
Getinge. DPTE®-XS Alpha Port: the original rapid transfer port. Getinge; accessed 6 November 2026. Source
Boom FA, et al. Microbiological monitoring during aseptic handling: methods, limits and interpretation of results. Eur J Pharm Sci. 2020;155:105540. doi:10.1016/j.ejps.2020.105540. Source
United States Pharmacopeial Convention. General Chapter <797> Pharmaceutical Compounding — Sterile Preparations. USP–NF; official 1 November 2023. Source